KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Debt to Equity (2018 - 2025)

Historic Debt to Equity for Twist Bioscience (TWST) over the last 6 years, with Q4 2025 value amounting to $0.03.

  • Twist Bioscience's Debt to Equity fell 3.38% to $0.03 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.03, marking a year-over-year decrease of 3.38%. This contributed to the annual value of $0.03 for FY2025, which is N/A changed from last year.
  • Per Twist Bioscience's latest filing, its Debt to Equity stood at $0.03 for Q4 2025, which was down 3.38% from $0.03 recorded in Q3 2025.
  • Twist Bioscience's Debt to Equity's 5-year high stood at $0.03 during Q1 2025, with a 5-year trough of $0.0 in Q3 2021.
  • Its 3-year average for Debt to Equity is $0.02, with a median of $0.03 in 2025.
  • Over the last 5 years, Twist Bioscience's Debt to Equity had its largest YoY gain of 13377.38% in 2021, and its largest YoY loss of 8102.79% in 2021.
  • Quarter analysis of 3 years shows Twist Bioscience's Debt to Equity stood at $0.01 in 2021, then skyrocketed by 126.83% to $0.03 in 2024, then decreased by 0.03% to $0.03 in 2025.
  • Its Debt to Equity stands at $0.03 for Q4 2025, versus $0.03 for Q3 2025 and $0.03 for Q2 2025.